Dimed S.A. Distribuidora de Medicamentos Stock Forecast for 2023 - 2025 - 2030

Updated on 03/29/2024

Stock Rating
18
Price Target
R$16.25
Consensus
Outperform
Upside
36.55%
Analysts
0
Stock Rating
18
Upside
36.55%
Analysts
0
Price Target
R$16.25

Dimed S.A. Distribuidora de Medicamentos Stock Forecast and Price Target

Year-long price target forecasts from prominent analysts have recently been released for Dimed S.A. Distribuidora de Medicamentos, with an average price target of R$16.25. This potential gain of 36.55 percent from the previous closing price in March, 2024 is calculated on a high forecast of R$23.00 and a low estimate of R$14.00. If you're interested in PNVL3 stock, it's important to compare it to other companies in the industry.

R$16.25

36.55% Upside

Outperform
Outperform

Dimed S.A. Distribuidora de Medicamentos Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Dimed S.A. Distribuidora de Medicamentos has seen a decline in its Price, from R$9.80 to R$0.00 – a 100.00% decrease. For next year, analysts predict Fair Value of R$25.35, which would mean an increase of 100.00%. Over the next seven years, experts predict that Dimed S.A. Distribuidora de Medicamentos's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
R$25.35
2025 Fair Value Forecast
R$44.94
2026 Fair Value Forecast
R$38.41
2027 Fair Value Forecast
R$22.20
2028 Fair Value Forecast
R$25.64
2029 Fair Value Forecast
R$32.18
2030 Fair Value Forecast
R$36.40

Dimed S.A. Distribuidora de Medicamentos Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Dimed S.A. Distribuidora de Medicamentos's Revenue has grown by 41.55%, rising from R$2.82B to R$3.99B. According to the 0 analysts polled, in the next year, Dimed S.A. Distribuidora de Medicamentos's Revenue will fall by 16.98%, reaching R$3.31B. By 2030, professionals believe that Dimed S.A. Distribuidora de Medicamentos's Revenue will have decreased by 15.46%, falling to R$3.37B.

2023 Rev Forecast
R$3.31B
2024 Rev Forecast
R$3.19B
2025 Rev Forecast
R$3.24B
2026 Rev Forecast
R$3.49B
2027 Rev Forecast
R$3.43B
2028 Rev Forecast
R$3.35B
2029 Rev Forecast
R$3.32B
2030 Rev Forecast
R$3.37B

Dimed S.A. Distribuidora de Medicamentos Dividend per Share Forecast for 2023 - 2025 - 2030

In the last year, Dimed S.A. Distribuidora de Medicamentos's Dividend per Share has grown, rising from R$0.14 to R$0.17 – a growth of 21.43%. In the next year, analysts believe that Dividend per Share will reach R$0.46 – an increase of 170.59%. For the next seven years, the forecast is for Dividend per Share to grow by 161.61%.

2024 DPS Forecast
R$0.46
2025 DPS Forecast
R$0.60
2026 DPS Forecast
R$0.39
2027 DPS Forecast
R$0.35
2028 DPS Forecast
R$0.40
2029 DPS Forecast
R$0.47
2030 DPS Forecast
R$0.44

Dimed S.A. Distribuidora de Medicamentos Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
R$-24000000.00
2025 FCF Forecast
R$0.01B
2026 FCF Forecast
R$-24000000.00
2027 FCF Forecast
R$-19467200.00
2028 FCF Forecast
R$-8108088.80
2029 FCF Forecast
R$-16352663.76
2030 FCF Forecast
R$-22509986.76

Dimed S.A. Distribuidora de Medicamentos EBITDA Forecast for 2023 - 2025 - 2030

Dimed S.A. Distribuidora de Medicamentos's EBITDA has seen impressive growth In the last two years, rising from R$118.83M to R$180.29M – a growth of 51.72%. In the next year, analysts believe that EBITDA will reach R$358.67M – an increase of 98.94%. For the next seven years, the forecast is for EBITDA to grow by 153.98%.

2024 EBITDA Forecast
R$0.36B
2025 EBITDA Forecast
R$0.43B
2026 EBITDA Forecast
R$0.54B
2027 EBITDA Forecast
R$0.38B
2028 EBITDA Forecast
R$0.39B
2029 EBITDA Forecast
R$0.41B
2030 EBITDA Forecast
R$0.46B

Dimed S.A. Distribuidora de Medicamentos EBIT Forecast for 2023 - 2025 - 2030

In the last year, Dimed S.A. Distribuidora de Medicamentos's EBIT has grown by 12.39%, rising from R$91.45M to R$102.78M. For the next year, analysts predict that EBIT will reach R$267.50M – an increase of 160.26%. Over the next seven years, experts believe that Dimed S.A. Distribuidora de Medicamentos's EBIT will grow at a rate of 157.86%.

2024 EBIT Forecast
R$0.27B
2025 EBIT Forecast
R$0.35B
2026 EBIT Forecast
R$0.24B
2027 EBIT Forecast
R$0.21B
2028 EBIT Forecast
R$0.24B
2029 EBIT Forecast
R$0.28B
2030 EBIT Forecast
R$0.27B

Dimed S.A. Distribuidora de Medicamentos EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Dimed S.A. Distribuidora de Medicamentos has seen a decline in its EPS, from R$0.46 to R$0.00 – a 100.00% decrease. For next year, analysts predict EPS of R$1.19, which would mean an increase of 100.00%. Over the next seven years, experts predict that Dimed S.A. Distribuidora de Medicamentos's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
R$1.19
2025 EPS Forecast
R$2.11
2026 EPS Forecast
R$1.80
2027 EPS Forecast
R$1.04
2028 EPS Forecast
R$1.20
2029 EPS Forecast
R$1.51
2030 EPS Forecast
R$1.71